| Previous Close | 82.97 |
| Open | 83.39 |
| Bid | 82.28 x 100 |
| Ask | 82.37 x 200 |
| Day's Range | 82.13 - 83.39 |
| 52 Week Range | 63.76 - 86.27 |
| Volume | 5,135,785 |
| Avg. Volume | 10,189,364 |
| Market Cap | 107.46B |
| Beta | 0.91 |
| PE Ratio (TTM) | 8.94 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 2.08 (2.53%) |
| Ex-Dividend Date | 2017-09-14 |
| 1y Target Est | N/A |
- Zacks•6 hours ago
Should Value Investors Consider Gilead Sciences (GILD) Stock?
Gilead Sciences (GILD) appears to be a good choice for value investors right now, given its favorable metrics and estimate revisions.
- CNBC•7 hours ago
Your first trade for Tuesday, September 19
The "Fast Money" traders share their first moves as the market opens.
- Market Realist•8 hours ago
Taking On Exposure to Innovative Biotechnology Stocks
The iShares NASDAQ Biotechnology ETF (IBB) offers investors targeted exposure to biotechnology and pharmaceutical stocks listed on the NASDAQ.
